Liu, Yusi. “How Do Varying Concentrations and Treatment Durations of Anti-PDL1 Antibodies Affect HCT116 Cell Viability, Xenograft Tumor Size, and T Cell Activation, As Measured by MTT Assay, Tumor Weight, and IL-2 Production, Respectively?”. MedScien 2, no. 6 (December 31, 2024): 2912. Accessed November 4, 2026. https://ms.deanfrancis.press/article/view/1005.